DNMT1 and cancer: DNMT inhibitors, such as Vidaza® (5-azacytidine, Celgene) and Dacogen® (decitabine or 5-aza-2’-deoxycytidine, SuperGen) have been approved by the FDA for cancer therapy.86 A few studies have focused on EBV-associated malignancies.